M&A Deal Summary

MedTest DX Acquires Clinitox Diagnostix

On October 27, 2014, MedTest DX acquired healthcare services company Clinitox Diagnostix

Acquisition Highlights
  • This is MedTest DX’s 1st transaction in the Healthcare Services sector.
  • This is MedTest DX’s 1st transaction in Canada.
  • This is MedTest DX’s 1st transaction in Ontario.

M&A Deal Summary

Date 2014-10-27
Target Clinitox Diagnostix
Sector Healthcare Services
Buyer(s) MedTest DX
Deal Type Add-on Acquisition

Target

Clinitox Diagnostix

Mississauga, Ontario, Canada
Clinitox Diagnostix, Inc. provides drugs of abuse confirmatory testing capabilities via liquid chromatography/mass spectrophotometry (LC/MS) instrumentation and associated reagents and consumables as pre-packaged kits.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MedTest DX

Canton, Michigan, United States

Category Company
Founded 2011
Sector Healthcare Services
DESCRIPTION

MedTest DX, Inc. designs, manufactures, and markets a range of chemistry instruments and provides supporting reagents and instrument service to physician offices, hospitals, reference laboratories, and research facilities. MedTest Dx was founded in 2011 and is based in Canton, Michigan.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2014 M&A 1 of 1